News about Regulation

India's Ministry of Health Revises Pharmaceutical Manufacturing Rules

India's Ministry of Health Revises Pharmaceutical Manufacturing Rules

The move is seen as a step towards aligning with international quality standards and ensuring the production of safe and high-quality drugs.

Regulation | 08/01/2024 | By Manvi |  1512

Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector

Department of Pharmaceuticals to Launch Scheme for Promotion of Research and Innovation in Pharma-MedTech Sector

Union Cabinet has already approved the National Policy on Research and Development and Innovation in the Pharma-Med Tech Sector in India.

Regulation | 30/08/2023 | By Manvi |  1093

USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma

USFDA Conducts Pre-Market Inspection at Pashamylaram Facility of Gland Pharma

The Company is committed to address the observations and will submit its response to USFDA within the stipulated time.

Regulation | 28/08/2023 | By Manvi |  818

Gland Pharma Receives EIR From USFDA For Dundigal Facility

Gland Pharma Receives EIR From USFDA For Dundigal Facility

Gland Pharma shares gained nearly 3 percent in trade after receiving EIR.

Regulation | 25/08/2023 | By Manvi |  994

Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility

Torrent Pharmaceuticals Receives EIR from USFDA for Dahej Facility

The Dahej facility was placed under OAI by the USFDA based on the March 2019 Inspection outcome.

Regulation | 25/08/2023 | By Manvi |  1904

Glenmark Pharma settles drug pricing case with US Department of Justice

Glenmark Pharma settles drug pricing case with US Department of Justice

Glenmark Pharma settles drug pricing case with US Department of Justice

Regulation | 24/08/2023 | By Sudeep Soparkar |  851

Sun Pharma, Alembic recall drugs in US market

Sun Pharma, Alembic recall drugs in US market

Sun Pharma, Alembic recall drugs in US market

Regulation | 22/08/2023 | By Sudeep Soparkar |  877

Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout

Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout

Flawless Pharma Pvt Ltd will spend USD 100 Million in Hong Kong and China Assets & Patents buyout

Regulation | 03/08/2023 | By Sudeep Soparkar |  1293

Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities

Lupin Announces Resolution of US FDA Warning Letter for its Goa and Pithampur Facilities

This is after the satisfactory evaluation of the corrective actions taken by the company in response to the Warning Letter that was issued on November 6, 2017.

Regulation | 28/07/2023 | By Manvi |  1050

Income Tax Survey at Ipca Laboratories Ltd's plants

Income Tax Survey at Ipca Laboratories Ltd's plants

The Income Tax Department has carried out survey proceedings at the Company's offices in Mumbai and at Sikkim manufacturing plants between 30th May, 2023 to 3rd June, 2023.

Regulation | 06/06/2023 | By Sudeep Soparkar |  764

 
 

 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members